Thomas P. Mathers, Chief Executive Officer at CoLucid Pharmaceuticals, Inc. (CLCD), sold 9,135 shares at $22.62 ($201K) on 2016-09-07, disclosed to the SEC on 2016-09-07.
Open-market sale of $201k CLCD by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.50 | 1,502 | $29K | 14.6% |
| 2 | $20.56 | 663 | $14K | 6.8% |
| 3 | $21.90 | 962 | $21K | 10.5% |
| 4 | $22.62 | 2,633 | $60K | 29.7% |
| 5 | $22.62 | 2,633 | $60K | 29.7% |
| 6 | $23.43 | 442 |
| $10K |
| 5.2% |
| 7 | $24.40 | 300 | $7K | 3.6% |
| Total | $21.98 avg | 9,135 | $201K | 100% |
| Filing → |
| CLCD | SELL | 2016-11-07 | $43K | — | Filing → |
| CLCD | SELL | 2016-10-05 | $111K | — | Filing → |
| CLCD | SELL | 2016-09-16 | $140K | — | Filing → |